Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.8600
+0.0150 (1.78%)
Oct 9, 2026, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 620.79 million as of October 9, 2026. It is the 27,091st most valuable company in the world and the 1,332nd biggest in Hong Kong. Its market cap has decreased by 61.70% in one year.
Market Cap
620.79M
Enterprise Value
-1.48B
Revenue
40.23M
Global Rank
Country Rank
#1,332 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 620.79M, a decrease of -96.17%. That is a compound annual growth rate of -46.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 620.79M | -38.95% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.13B |
| JW (Cayman) Therapeutics Co. | 1.12B |
| Cloudbreak Pharma | 1.10B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 814.78M |
| 3D Medicines | 568.08M |
| B&K Corporation | 460.04M |
| Wuhan YZY Biopharma | 427.44M |